- Home
- VOC vs ANVS Comparison
VOC vs ANVS Comparison
Compare VOC & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VOC | ANVS |
|---|---|---|
| Founded | 2010 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 50.7M | 111.3M |
| IPO Year | 2011 | 2020 |
Fundamental Metrics
Financial Performance| Metric | VOC | ANVS |
|---|---|---|
| Price | $2.77 | $3.59 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $13.50 |
| AVG Volume (30 Days) | 60.2K | ★ 614.8K |
| Earning Date | 01-01-0001 | 11-12-2025 |
| Dividend Yield | ★ 22.56% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.51 | N/A |
| Revenue | ★ $9,783,812.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $5.49 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.44 | $1.11 |
| 52 Week High | $5.12 | $5.60 |
Technical Indicators
Market Signals| Indicator | VOC | ANVS |
|---|---|---|
| Relative Strength Index (RSI) | 44.32 | 46.95 |
| Support Level | $2.72 | $3.49 |
| Resistance Level | $2.85 | $3.72 |
| Average True Range (ATR) | 0.08 | 0.30 |
| MACD | -0.01 | -0.10 |
| Stochastic Oscillator | 29.46 | 28.41 |
Price Performance
Historical ComparisonAbout VOC VOC Energy Trust Units of Beneficial Interest
VOC Energy Trust is a statutory trust. It is created to acquire and hold a term net profits interest for the benefit of the Trust unitholders. The underlying properties include VOC Brazos' net interests which are located in the states of Kansas and Texas. The trust is entitled to receive the net proceeds from the sale of production of oil and natural gas attributable to the underlying properties. The business and affairs of the Trust are managed by the Trustee, and neither VOC Brazos nor any of its affiliates has the ability to manage or influence the operations of the Trust.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.